Song et al. developed combinational antitumor immunotherapy using PEG and mannose doubly modified trimethyl chitosan NPs to deliver VEGF and PIGF siRNA to both M2 TAMs and breast cancer cells for antitumor immunotherapy [127]. The gene discussed is VEGFA; the disease is breast cancer.